Mediastinal and esophageal alterations after pulmonary vein isolatio

Not Applicable

Recruiting

• Conditions: I48.0; I48.1; I48.2; Paroxysmal atrial fibrillation; Persistent atrial fibrillation; Chronic atrial fibrillation

• Registration Number: DRKS00016006
• Lead Sponsor: niversitätsklinikum Münster;Klinik für Kardiologie II – Rhythmologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-12-17
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Full legal capacity of the patient, clinical indication for pulmonary vein isolation, voluntary participation and signed written informed consent

Exclusion Criteria

esophageal pathologies, prior pulmonary vein Isolation, contraindication for esophagogastroscopy / endosonography, pregnancy or breast-feeding, refusal of participation

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Esophageal, paraesophageal and mediastinal alterations and complications after pulmonary vein isolation

Secondary Outcome Measures

Name	Time	Method
Atrio-esophago Fistula, esophageal ulceration, mediastinal fibrosis, mediastinal edema, hospitalisation within 30 days after PVI, 30-days mortality, cardial complications, post-procedure femural access site complications